Atrial Fibrillation and Sleep Apnoea: Guilt by Association?

Heart Lung and Circulation

Volumn 26, Issue 9, 2017, Pages 902-910

  Al Falahi, Zaidon ^a   Williamson, Jonathan ^a   Dimitri, Hany ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

Atrial fibrillation; Myocardial substrate; Obstructive sleep apnoea; Remodelling

Indexed keywords

ADRENERGIC STIMULATION; ARRHYTHMOGENESIS; ATHEROGENESIS; ATRIAL FIBRILLATION; AUTONOMIC DYSFUNCTION; BODY MASS; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; LIFESTYLE MODIFICATION; LUNG GAS EXCHANGE; MYOCARDIAL DISEASE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SLEEP DISORDERED BREATHING; VASCULAR ENDOTHELIUM; COMPLICATION; DISEASE EXACERBATION; HEART ATRIUM; HEART ATRIUM REMODELING; POLYSOMNOGRAPHY; RISK FACTOR;

ATRIAL FIBRILLATION; ATRIAL REMODELING; DISEASE PROGRESSION; HEART ATRIA; HUMANS; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 85021239664     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2017.05.127     Document Type: Review

References (178)

1. Charles, D., Posthumous papers of the Pickwick Club. 1837, Chapman & Hall, London.
2. Osler, W.M.T., The principles and practice of medicine. 8th ed., 1918, D. Appleton, New York.
3. Guilleminault, C., Tilkian, A., Dement, W.C., The sleep apnea syndromes. Annual Review of Medicine 27 (1976), 465–484.
4. Sullivan, C.E., Issa, F.G., Pathophysiological mechanisms in obstructive sleep apnea. Sleep 3 (1980), 235–246.
5. Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research. Sleep 22 (1999), 667–689.
6. Young, T., Palta, M., Dempsey, J., Peppard, P.E., Nieto, F.J., Hla, K.M., Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ: official publication of the State Medical Society of Wisconsin 108 (2009), 246–249.
7. Kuhlo, W., Doll, E., Franck, M.C., [Successful management of Pickwickian syndrome using long-term tracheostomy]. Deutsche medizinische Wochenschrift (1946) 94 (1969), 1286–1290.
8. Tilkian, A.G., Guilleminault, C., Schroeder, J.S., Lehrman, K.L., Simmons, F.B., Dement, W.C., Sleep-induced apnea syndrome: Prevalence of cardiac arrhythmias and their reversal after tracheostomy. The American Journal of Medicine 63 (1977), 348–358.
9. Sullivan, C.E., Issa, F.G., Berthon-Jones, M., Eves, L., Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet (London, England) 1 (1981), 862–865.
10. Einthoven, W., Le télécardiogramme. Arch Int Physiol 4 (1906), 132–164.
11. Mathewson, F.A.L., Jackh, H., The telecardiogram. American Heart Journal 49 (1955), 77–82.
12. Chugh, S.S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E.J., et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation, 129, 2014, 837.
13. Kannel, W.B., Wolf, P.A., Benjamin, E.J., Levy, D., Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998), 2n–9n.
14. Benjamin, E.J., Wolf, P.A., D'Agostino, R.B., Silbershatz, H., Kannel, W.B., Levy, D., Impact of Atrial Fibrillation on the Risk of Death. Circulation, 98, 1998, 946.
15. Wang, T.J., Larson, M.G., Levy, D., Vasan, R.S., Leip, E.P., Wolf, P.A., et al. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality. Circulation, 107, 2003, 2920.
16. Murray, C.J.L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A.D., Michaud, C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380:9859 (2012), 2197–2223.
17. January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cleveland, J.C., et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130 (2014), e199–e267.
18. He, J., Kryger, M.H., Zorick, F.J., Conway, W., Roth, T., Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94 (1988), 9–14.
19. Partinen, M., Guilleminault, C., Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 97 (1990), 27–32.
20. Hung, J., Whitford, E.G., Parsons, R.W., Hillman, D.R., Association of sleep apnoea with myocardial infarction in men. Lancet (London, England) 336 (1990), 261–264.
21. Tilkian, A.G., Guilleminault, C., Schroeder, J.S., Lehrman, K.L., Simmons, F.B., Dement, W.C., Hemodynamics in sleep-induced apnea: Studies during wakefulness and sleep. Ann Intern Med 85 (1976), 714–719.
22. Guilleminault, C., Eldridge, F.L., Simmon, F.B., Dement, W.C., Sleep apnea syndrome. Can it induce hemodynamic changes?. The Western Journal of Medicine 123 (1975), 7–16.
23. Guilleminault, C., Connolly, S.J., Winkle, R.A., Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 52 (1983), 490–494.
24. Wilcox, I., McNamara, S.G., Collins, F.L., Grunstein, R.R., Sullivan, C.E., “Syndrome Z”: the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53:Suppl 3 (1998), S25–S28.
25. Lattimore Jo-DL, Celermajer, D.S., Wilcox, I., Obstructive Sleep Apnea and Cardiovascular Disease. Journal of the American College of Cardiology 41 (2003), 1429–1437.
26. Somers, V.K., White, D.P., Amin, R., Abraham, W.T., Costa, F., Culebras, A., et al. Sleep Apnea and Cardiovascular Disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement From the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing In Collaboration With the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Journal of the American College of Cardiology 52 (2008), 686–717.
27. Wilcox, I., Semsarian, C., Obstructive Sleep Apnea: A Respiratory Syndrome With Protean Cardiovascular Manifestations. Journal of the American College of Cardiology 54 (2009), 1810–1812.
28. Devulapally, K., Pongonis, R. Jr., Khayat, R., OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea. Heart Failure Reviews 14 (2009), 155–164.
29. Khayat, R., Patt, B., Hayes, D., Obstructive sleep apnea: the new cardiovascular disease: Part I: obstructive sleep apnea and the pathogenesis of vascular disease. Heart Failure Reviews 14 (2009), 143–153.
30. Somers, V.K., Sleep–a new cardiovascular frontier. The New England Journal of Medicine 353 (2005), 2070–2073.
31. Gottlieb, D.J., Yenokyan, G., Newman, A.B., O'Connor, G.T., Punjabi, N.M., Quan, S.F., et al. Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure. The Sleep Heart Health Study. Circulation 122 (2010), 352–360.
32. Bearpark, H., Elliott, L., Grunstein, R., Cullen, S., Schneider, H., Althaus, W., et al. Snoring and sleep apnea. A population study in Australian men. American Journal of Respiratory and Critical Care Medicine 151 (1995), 1459–1465.
33. Peppard, P.E., Young, T., Barnet, J.H., Palta, M., Hagen, E.W., Hla, K.M., Increased Prevalence of Sleep-Disordered Breathing in Adults. American Journal of Epidemiology 177 (2013), 1006–1014.
34. Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., Badr, S., The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults. New England Journal of Medicine 328 (1993), 1230–1235.
35. Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013;2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet 384:9945 (2014), 766–781.
36. Newman, A.B., Foster, G., Givelber, R., Nieto, F.J., Redline, S., Young, T., Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Archives of Internal Medicine 165 (2005), 2408–2413.
37. Young, T., Peppard, P.E., Taheri, S., Excess weight and sleep-disordered breathing. Journal of Applied Physiology (Bethesda, Md: 1985)(99), 2005, 1592–1599.
38. Peppard, P.E., Young, T., Palta, M., Dempsey, J., Skatrud, J., Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 284 (2000), 3015–3021.
39. Young, T., Evans, L., Finn, L., Palta, M., Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20 (1997), 705–706.
40. Kapur, V., Strohl, K.P., Redline, S., Iber, C., O'Connor, G., Nieto, J., Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath 6:2 (2002), 49–54.
41. Ip, M.S., Lam, B., Lauder, I.J., Tsang, K.W., Chung, K.F., Mok, Y.W., et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 119 (2001), 62–69.
42. Li, K.K., Kushida, C., Powell, N.B., Riley, R.W., Guilleminault, C., Obstructive sleep apnea syndrome: a comparison between Far-East Asian and white men. The Laryngoscope 110 (2000), 1689–1693.
43. Deegan, P.C., McNicholas, W.T., Pathophysiology of obstructive sleep apnoea. The European Respiratory Journal 8 (1995), 1161–1178.
44. Johns, M.W., A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991), 540–545.
45. American Academy of Sleep M, International classification of sleep disorders. 2014, American Academy of Sleep Medicine, Darien, IL.
46. Wilcox, I., Chan, K.H., Dimitri, H., Diagnosis and Treatment of Obstructive Sleep Apnea Is Key to Achieving Optimal Results After Catheter Ablation of Atrial Fibrillation. Journal of the American College of Cardiology 63 (2014), 607–608.
47. Peppard, P.E., Young, T., Palta, M., Skatrud, J., Prospective study of the association between sleep-disordered breathing and hypertension. The New England Journal of Medicine 342 (2000), 1378–1384.
48. Allessie, M.A., Boyden, P.A., Camm, A.J., Kléber, A.G., Lab, M.J., Legato, M.J., et al. Pathophysiology and Prevention of Atrial Fibrillation. Circulation 103 (2001), 769–777.
49. Schoonderwoerd, B.A., Smit, M.D., Pen, L., Van Gelder, I.C., New risk factors for atrial fibrillation: causes of ‘not-so-lone atrial fibrillation’. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 10 (2008), 668–673.
50. Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M.A., Maseri, A., Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation. Circulation 96 (1997), 1180–1184.
51. Haissaguerre, M., Jais, P., Shah, D.C., Takahashi, A., Hocini, M., Quiniou, G., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. The New England Journal of Medicine 339 (1998), 659–666.
52. Chen, S.A., Hsieh, M.H., Tai, C.T., Tsai, C.F., Prakash, V.S., Yu, W.C., et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 100 (1999), 1879–1886.
53. Nattel, S., Burstein, B., Dobrev, D., Atrial Remodeling and Atrial Fibrillation. Mechanisms and Implications 1 (2008), 62–73.
54. De Jong, A.M., Maass, A.H., Oberdorf-Maass, S.U., Van Veldhuisen, D.J., Van Gilst, W.H., Van Gelder, I.C., Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovascular Research 89 (2011), 754–765.
55. Nattel, S., Harada, M., Atrial Remodeling and Atrial Fibrillation: Recent Advances and Translational Perspectives. Journal of the American College of Cardiology 63 (2014), 2335–2345.
56. Dimitri, H., Ng, M., Brooks, A.G., Kuklik, P., Stiles, M.K., Lau, D.H., et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm 9 (2012), 321–327.
57. Moe, G.K., Abildskov, J.A., Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. American Heart Journal 58 (1959), 59–70.
58. Moe, G.K., On Multiple Wavelet Hypothesis Of Atrial Fibrillation. Arch Int Pharmacodyn Ther, 140, 1962 183–188.
59. Ausma, J., Wijffels, M., Thone, F., Wouters, L., Allessie, M., Borgers, M., Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96 (1997), 3157–3163.
60. Burstein, B., Qi, X.Y., Yeh, Y.H., Calderone, A., Nattel, S., Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res 76 (2007), 442–452.
61. Wakili, R., Voigt, N., Kääb, S., Dobrev, D., Nattel, S., Recent advances in the molecular pathophysiology of atrial fibrillation. The Journal of Clinical Investigation 121 (2011), 2955–2968.
62. Stiles, M.K., John, B., Wong, C.X., Kuklik, P., Brooks, A.G., Lau, D.H., et al. Paroxysmal Lone Atrial Fibrillation Is Associated With an Abnormal Atrial Substrate: Characterizing the “Second Factor”. Journal of the American College of Cardiology 53 (2009), 1182–1191.
63. Wijffels, M.C.E.F., Kirchhof, C.J.H.J., Dorland, R., Allessie, M.A., Atrial Fibrillation Begets Atrial Fibrillation. Circulation, 92, 1995, 1954.
64. Cadby, G., McArdle, N., Briffa, T., Hillman, D.R., Simpson, L., Knuiman, M., et al. Severity of OSA Is an Independent Predictor of Incident Atrial Fibrillation Hospitalization in a Large Sleep-Clinic Cohort. Chest 148 (2015), 945–952.
65. Mehra, R., Benjamin, E.J., Shahar, E., Gottlieb, D.J., Nawabit, R., Kirchner, H.L., et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. American Journal of Respiratory and Critical Care Medicine 173 (2006), 910–916.
66. Gami, A.S., Pressman, G., Caples, S.M., Kanagala, R., Gard, J.J., Davison, D.E., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110 (2004), 364–367.
67. Stevenson, I.H., Teichtahl, H., Cunnington, D., Ciavarella, S., Gordon, I., Kalman, J.M., Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J 29 (2008), 1662–1669.
68. Kanagala, R., Murali, N.S., Friedman, P.A., Ammash, N.M., Gersh, B.J., Ballman, K.V., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107 (2003), 2589–2594.
69. Patel, D., Mohanty, P., Di Biase, L., Shaheen, M., Lewis, W.R., Quan, K., et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circulation Arrhythmia and Electrophysiology 3 (2010), 445–451.
70. Naruse, Y., Tada, H., Satoh, M., Yanagihara, M., Tsuneoka, H., Hirata, Y., et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 10 (2013), 331–337.
71. Neilan, T.G., Farhad, H., Dodson, J.A., Shah, R.V., Abbasi, S.A., Bakker, J.P., et al. Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2, 2013, e000421.
72. Fein, A.S., Shvilkin, A., Shah, D., Haffajee, C.I., Das, S., Kumar, K., et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 62 (2013), 300–305.
73. Szymanski, F.M., Filipiak, K.J., Platek, A.E., Hrynkiewicz-Szymanska, A., Kotkowski, M., Kozluk, E., et al. Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations – a long-term prospective, cross-sectional cohort study. Sleep Breath 19 (2015), 849–856.
74. Qureshi, W.T., Nasir, U.B., Alqalyoobi, S., O'Neal, W.T., Mawri, S., Sabbagh, S., et al. Meta-Analysis of Continuous Positive Airway Pressure as a Therapy of Atrial Fibrillation in Obstructive Sleep Apnea. Am J Cardiol 116 (2015), 1767–1773.
75. Kawakami, H., Nagai, T., Fujii, A., Uetani, T., Nishimura, K., Inoue, K., et al. Apnea-hypopnea index as a predictor of atrial fibrillation recurrence following initial pulmonary vein isolation: usefulness of type-3 portable monitor for sleep-disordered breathing. J Interv Card Electrophysiol 47 (2016), 237–244.
76. Abe, H., Takahashi, M., Yaegashi, H., Eda, S., Tsunemoto, H., Kamikozawa, M., et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart and Vessels 25 (2010), 63–69.
77. Monahan, K., Storfer-Isser, A., Mehra, R., Shahar, E., Mittleman, M., Rottman, J., et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 54 (2009), 1797–1804.
78. Mitchell, A.R., Spurrell, P.A., Sulke, N., Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation. American Heart Journal 146 (2003), 902–907.
79. Youn, J.-Y., Zhang, J., Zhang, Y., Chen, H., Liu, D., Ping, P., et al. Oxidative Stress in Atrial Fibrillation: An Emerging Role of NADPH Oxidase. Journal of Molecular and Cellular Cardiology 62 (2013), 72–79.
80. Korantzopoulos, P., Kolettis, T.M., Galaris, D., Goudevenos, J.A., The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007), 135–143.
81. Elahi, M.M., Flatman, S., Matata, B.M., Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. European Journal of Cardiovascular Prevention and Rehabilitation: official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 15 (2008), 735–741.
82. Chang, J.P., Chen, M.C., Liu, W.H., Yang, C.H., Chen, C.J., Chen, Y.L., et al. Atrial myocardial nox2 containing NADPH oxidase activity contribution to oxidative stress in mitral regurgitation: potential mechanism for atrial remodeling. Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology 20 (2011), 99–106.
83. Babusikova, E., Kaplan, P., Lehotsky, J., Jesenak, M., Dobrota, D., Oxidative modification of rat cardiac mitochondrial membranes and myofibrils by hydroxyl radicals. General Physiology and Biophysics 23 (2004), 327–335.
84. Mihm, M.J., Yu, F., Carnes, C.A., Reiser, P.J., McCarthy, P.M., Van Wagoner, D.R., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001), 174–180.
85. Lai, L.P., Su, M.J., Lin, J.L., Lin, F.Y., Tsai, C.H., Chen, Y.S., et al. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 33 (1999), 1231–1237.
86. Bukowska, A., Schild, L., Keilhoff, G., Hirte, D., Neumann, M., Gardemann, A., et al. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Experimental Biology and Medicine (Maywood, NJ) 233 (2008), 558–574.
87. Liu, H.G., Liu, K., Zhou, Y.N., Xu, Y.J., Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population. Chinese Medical Journal 122 (2009), 1369–1374.
88. Dyugovskaya, L., Lavie, P., Lavie, L., Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. American Journal of Respiratory and Critical Care Medicine 165 (2002), 934–939.
89. Alonso-Fernandez, A., Garcia-Rio, F., Arias, M.A., Hernanz, A., de la Pena, M., Pierola, J., et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 64 (2009), 581–586.
90. Barcelo, A., de la Pena, M., Ayllon, O., Vega-Agapito, M.V., Pierola, J., Perez, G., et al. Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea. Respiration; International Review of Thoracic Diseases 77 (2009), 85–90.
91. Ip, M.S., Lam, B., Chan, L.Y., Zheng, L., Tsang, K.W., Fung, P.C., et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine 162 (2000), 2166–2171.
92. Ozkan, Y., Firat, H., Simsek, B., Torun, M., Yardim-Akaydin, S., Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 12 (2008), 149–154.
93. Schulz, R., Schmidt, D., Blum, A., Lopes-Ribeiro, X., Lucke, C., Mayer, K., et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 55 (2000), 1046–1051.
94. Yuksel, M., Okur, H.K., Pelin, Z., Ogunc, A.V., Ozturk, L., Arginase activity and nitric oxide levels in patients with obstructive sleep apnea syndrome. Clinics (Sao Paulo, Brazil) 69 (2014), 247–252.
95. Barcelo, A., Barbe, F., de la Pena, M., Vila, M., Perez, G., Pierola, J., et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. The European Respiratory Journal 27 (2006), 756–760.
96. Christou, K., Moulas, A.N., Pastaka, C., Gourgoulianis, K.I., Antioxidant capacity in obstructive sleep apnea patients. Sleep Medicine 4 (2003), 225–228.
97. Faure, P., Tamisier, R., Baguet, J.P., Favier, A., Halimi, S., Levy, P., et al. Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. The European Respiratory Journal 31 (2008), 1046–1053.
98. Hoffmann, M.S., Singh, P., Wolk, R., Romero-Corral, A., Raghavakaimal, S., Somers, V.K., Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. Antioxidants & Redox Signaling 9 (2007), 661–669.
99. Lavie, L., Vishnevsky, A., Lavie, P., Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 (2004), 123–128.
100. Stradling, J.R., Schwarz, E.I., Schlatzer, C., Manuel, A.R., Lee, R., Antoniades, C., et al. Biomarkers of oxidative stress following continuous positive airway pressure withdrawal: data from two randomised trials. The European Respiratory Journal 46 (2015), 1065–1071.
101. Barcelo, A., Miralles, C., Barbe, F., Vila, M., Pons, S., Agusti, A.G., Abnormal lipid peroxidation in patients with sleep apnoea. The European Respiratory Journal 16 (2000), 644–647.
102. Carpagnano, G.E., Kharitonov, S.A., Resta, O., Foschino-Barbaro, M.P., Gramiccioni, E., Barnes, P.J., 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124 (2003), 1386–1392.
103. Hopps, E., Canino, B., Calandrino, V., Montana, M., Lo Presti R, Caimi G. Lipid peroxidation and protein oxidation are related to the severity of OSAS. European Review for Medical and Pharmacological Sciences 18 (2014), 3773–3778.
104. Ozben, S., Huseyinoglu, N., Hanikoglu, F., Guvenc, T.S., Yildirim, B.Z., Cort, A., et al. Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea. European Journal of Clinical Investigation 44 (2014), 1045–1052.
105. Schulz, R., Mahmoudi, S., Hattar, K., Sibelius, U., Olschewski, H., Mayer, K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. American Journal of Respiratory and Critical Care Medicine 162 (2000), 566–570.
106. Del Ben, M., Fabiani, M., Loffredo, L., Polimeni, L., Carnevale, R., Baratta, F., et al. Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment. BMC Pulmonary Medicine, 12, 2012, 36.
107. Can, M., Uygur, F., Tanriverdi, H., Acikgoz, B., Alper, B., Guven, B., Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea. Immunologic Research 64 (2016), 1179–1184.
108. Guilleminault, C., Kirisoglu, C., Ohayon, M.M., C-reactive protein and sleep-disordered breathing. Sleep 27 (2004), 1507–1511.
109. Meier-Ewert, H.K., Ridker, P.M., Rifai, N., Regan, M.M., Price, N.J., Dinges, D.F., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43 (2004), 678–683.
110. Mermigkis, C., Bouloukaki, I., Mermigkis, D., Kallergis, E., Mavroudi, E., Varouchakis, G., et al. CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?. Sleep Breath 16 (2012), 813–819.
111. Nural, S., Gunay, E., Halici, B., Celik, S., Unlu, M., Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36 (2013), 66–74.
112. Ohga, E., Tomita, T., Wada, H., Yamamoto, H., Nagase, T., Ouchi, Y., Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. Journal of Applied Physiology (Bethesda, Md: 1985)(94), 2003, 179–184.
113. Punjabi, N.M., Beamer, B.A., C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30 (2007), 29–34.
114. Schiza, S.E., Mermigkis, C., Panagiotis, P., Bouloukaki, I., Kallergis, E., Tzanakis, N., et al. C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. European Journal of Clinical Investigation 40 (2010), 968–975.
115. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Kales, A., Tyson, K., Chrousos, G.P., Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. The Journal of Clinical Endocrinology and Metabolism 82 (1997), 1313–1316.
116. Hoyos, C.M., Melehan, K.L., Liu, P.Y., Grunstein, R.R., Phillips, C.L., Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literature. Sleep Med Rev 20 (2015), 15–26.
117. Matsuzawa, Y., Kwon, T.G., Lennon, R.J., Lerman, L.O., Lerman, A., Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis. Journal of the American Heart Association, 4, 2015.
118. Poredos, P., Endothelial dysfunction in the pathogenesis of atherosclerosis. Clinical and Applied Thrombosis/Hemostasis: official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 7 (2001), 276–280.
119. Rossi, R., Nuzzo, A., Origliani, G., Modena, M.G., Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 51 (2008), 997–1002.
120. Seif, F., Patel, S.R., Walia, H., Rueschman, M., Bhatt, D.L., Gottlieb, D.J., et al. Association between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden. Journal of Sleep Research 22 (2013), 443–451.
121. Yeboah, J., Crouse, J.R., Hsu, F.C., Burke, G.L., Herrington, D.M., Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115 (2007), 2390–2397.
122. Sawatari, H., Chishaki, A., Nishizaka, M., Tokunou, T., Adachi, S., Yoshimura, C., et al. Cumulative Hypoxemia During Sleep Predicts Vascular Endothelial Dysfunction in Patients With Sleep-Disordered Breathing. American Journal of Hypertension 29 (2016), 458–463.
123. Schwarz, E.I., Puhan, M.A., Schlatzer, C., Stradling, J.R., Kohler, M., Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis. Respirology (Carlton, Vic) 20 (2015), 889–895.
124. Lattimore, J.L., Wilcox, I., Skilton, M., Langenfeld, M., Celermajer, D.S., Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61 (2006), 491–495.
125. Heppell, R.M., Berkin, K.E., McLenachan, J.M., Davies, J.A., Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart (British Cardiac Society) 77 (1997), 407–411.
126. Mondillo, S., Sabatini, L., Agricola, E., Ammaturo, T., Guerrini, F., Barbati, R., et al. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation. Int J Cardiol 75 (2000), 227–232.
127. O'Neal, W.T., Efird, J.T., Yeboah, J., Nazarian, S., Alonso, A., Heckbert, S.R., et al. Brachial flow-mediated dilation and incident atrial fibrillation: the multi-ethnic study of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 34 (2014), 2717–2720.
128. Stamboul, K., Lorin, J., Lorgis, L., Guenancia, C., Beer, J.C., Touzery, C., et al. Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction. PLoS One, 10, 2015, e0131439.
129. Lu, Z., Nie, L., He, B., Yu, L., Salim, M., Huang, B., et al. Increase in vulnerability of atrial fibrillation in an acute intermittent hypoxia model: importance of autonomic imbalance. Autonomic Neuroscience: Basic & Clinical 177 (2013), 148–153.
130. Coumel, P., Paroxysmal atrial fibrillation: a disorder of autonomic tone?. Eur Heart J 15:Suppl A (1994), 9–16.
131. Patterson, E., Lazzara, R., Szabo, B., Liu, H., Tang, D., Li, Y.H., et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol 47 (2006), 1196–1206.
132. Parati, G., Di Rienzo, M., Bonsignore, M.R., Insalaco, G., Marrone, O., Castiglioni, P., et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. Journal of Hypertension 15 (1997), 1621–1626.
133. Otsuka, K., [Nasal CPAP treatment and hypertension and altered cardiovascular variability associated with obstructive sleep apnea (OSA)]. Nihon Rinsho Japanese Journal of Clinical Medicine 59 (2001), 983–991.
134. Narkiewicz, K., van de Borne, P.J., Cooley, R.L., Dyken, M.E., Somers, V.K., Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98 (1998), 772–776.
135. Narkiewicz, K., Somers, V.K., Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiologica Scandinavica 177 (2003), 385–390.
136. Narkiewicz, K., Montano, N., Cogliati, C., van de Borne, P.J., Dyken, M.E., Somers, V.K., Altered cardiovascular variability in obstructive sleep apnea. Circulation 98 (1998), 1071–1077.
137. Yamaguchi, K., Ohki, N., Kobayashi, M., Satoya, N., Inoue, Y., Onizawa, S., et al. Estimation of parasympathetic nerve function during sleep in patients with obstructive sleep apnea by instantaneous time-frequency analysis. Sleep Medicine 15 (2014), 33–41.
138. Noda, A., Nakata, S., Koike, Y., Miyata, S., Kitaichi, K., Nishizawa, T., et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertension Research: official journal of the Japanese Society of Hypertension 30 (2007), 669–676.
139. da Silva, S.P., Hulce, V.D., Backs, R.W., Effects of obstructive sleep apnea on autonomic cardiac control during sleep. Sleep Breath 13 (2009), 147–156.
140. Carlson, J.T., Hedner, J.A., Sellgren, J., Elam, M., Wallin, B.G., Depressed baroreflex sensitivity in patients with obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine 154 (1996), 1490–1496.
141. Baguet, J.P., Levy, P., Barone-Rochette, G., Tamisier, R., Pierre, H., Peeters, M., et al. Masked hypertension in obstructive sleep apnea syndrome. Journal of Hypertension 26 (2008), 885–892.
142. de Vos, C.B., Nieuwlaat, R., Crijns, H.J., Camm, A.J., LeHeuzey, J.Y., Kirchhof, C.J., et al. Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. Eur Heart J 29 (2008), 632–639.
143. Stevenson, I.H., Roberts-Thomson, K.C., Kistler, P.M., Edwards, G.A., Spence, S., Sanders, P., et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm 7 (2010), 1263–1270.
144. Cloward, T.V., Walker, J.M., Farney, R.J., Anderson, J.L., Left Ventricular Hypertrophy Is a Common Echocardiographic Abnormality in Severe Obstructive Sleep Apnea and Reverses With Nasal Continuous Positive Airway Pressure*. Chest 124 (2003), 594–601.
145. Pujante, P., Abreu, C., Moreno, J., Barrero, E.A., Azcarate, P., Campo, A., et al. Obstructive sleep apnea severity is associated with left ventricular mass independent of other cardiovascular risk factors in morbid obesity. Journal of Clinical Sleep Medicine: JCSM: official publication of the American Academy of Sleep Medicine 9 (2013), 1165–1171.
146. Javaheri, S., Sharma, R.K., Wang, R., Weng, J., Rosen, B.D., Bluemke, D.A., et al. Association between Obstructive Sleep Apnea and Left Ventricular Structure by Age and Gender: the Multi-Ethnic Study of Atherosclerosis. Sleep 39 (2016), 523–529.
147. Laaban, J.P., Pascal-Sebaoun, S., Bloch, E., Orvoen-Frija, E., Oppert, J.M., Huchon, G., Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 122 (2002), 1133–1138.
148. Korcarz, C.E., Peppard, P.E., Young, T.B., Chapman, C.B., Hla, K.M., Barnet, J.H., et al. Effects of Obstructive Sleep Apnea and Obesity on Cardiac Remodeling: The Wisconsin Sleep Cohort Study. Sleep 39 (2016), 1187–1195.
149. Fung, J.W., Li, T.S., Choy, D.K., Yip, G.W., Ko, F.W., Sanderson, J.E., et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 121 (2002), 422–429.
150. Sforza, E., Laks, L., Grunstein, R.R., Krieger, J., Sullivan, C.E., Time course of pulmonary artery pressure during sleep in sleep apnoea syndrome: role of recurrent apnoeas. European Respiratory Journal, 11, 1998, 440.
151. Schafer, H., Hasper, E., Ewig, S., Koehler, U., Latzelsberger, J., Tasci, S., et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. The European Respiratory Journal 12 (1998), 679–684.
152. Hammerstingl, C., Schueler, R., Wiesen, M., Momcilovic, D., Pabst, S., Nickenig, G., et al. Effects of untreated obstructive sleep apnea on left and right ventricular myocardial function. International Journal of Cardiology 155 (2012), 465–469.
153. Vitarelli, A., Terzano, C., Saponara, M., Gaudio, C., Mangieri, E., Capotosto, L., et al. Assessment of Right Ventricular Function in Obstructive Sleep Apnea Syndrome and Effects of Continuous Positive Airway Pressure Therapy: A Pilot Study. Can J Cardiol 31 (2015), 823–831.
154. Chan, K.H., Wilcox, I., Obstructive sleep apnea: novel trigger and potential therapeutic target for cardiac arrhythmias. Expert Rev Cardiovasc Ther 8 (2010), 981–994.
155. Buda, A.J., Pinsky, M.R., Ingels, N.B. Jr., Daughters, G.T. 2nd, Stinson, E.B., Alderman, E.L., Effect of intrathoracic pressure on left ventricular performance. The New England Journal of Medicine 301 (1979), 453–459.
156. Brinker, J.A., Weiss, J.L., Lappe, D.L., Rabson, J.L., Summer, W.R., Permutt, S., et al. Leftward septal displacement during right ventricular loading in man. Circulation 61 (1980), 626–633.
157. Dursunoğlu, N., Dursunoğlu, D., Kılıç, M., Impact of Obstructive Sleep Apnea on Right Ventricular Global Function: Sleep Apnea and Myocardial Performance Index. Respiration; International Review of Thoracic Diseases 72 (2005), 278–284.
158. Chami, H.A., Devereux, R.B., Gottdiener, J.S., Mehra, R., Roman, M.J., Benjamin, E.J., et al. Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation 117 (2008), 2599–2607.
159. Romero-Corral, A., Somers, V.K., Pellikka, P.A., Olson, E.J., Bailey, K.R., Korinek, J., et al. Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest 132 (2007), 1863–1870.
160. Oliveira, W., Campos, O., Bezerra Lira-Filho, E., Cintra, F.D., Vieira, M., Ponchirolli, A., et al. Left Atrial Volume and Function in Patients With Obstructive Sleep Apnea Assessed by Real-Time Three-Dimensional Echocardiography. Journal of the American Society of Echocardiography 21 (2008), 1355–1361.
161. Otto, M.E., Belohlavek, M., Romero-Corral, A., Gami, A.S., Gilman, G., Svatikova, A., et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 99 (2007), 1298–1302.
162. Iwasaki, Y.K., Shi, Y., Benito, B., Gillis, M.A., Mizuno, K., Tardif, J.C., et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm 9 (2012), 1409–1416 e1.
163. Iwasaki, Y.K., Kato, T., Xiong, F., Shi, Y.F., Naud, P., Maguy, A., et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol 64 (2014), 2013–2023.
164. Kostin, S., Klein, G., Szalay, Z., Hein, S., Bauer, E.P., Schaper, J., Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54 (2002), 361–379.
165. Boldt, A., Wetzel, U., Lauschke, J., Weigl, J., Gummert, J., Hindricks, G., et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart (British Cardiac Society) 90 (2004), 400–405.
166. Oakes, R.S., Badger, T.J., Kholmovski, E.G., Akoum, N., Burgon, N.S., Fish, E.N., et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119 (2009), 1758–1767.
167. Bishop, J.E., Regulation of cardiovascular collagen deposition by mechanical forces. Molecular Medicine Today 4 (1998), 69–75.
168. Spach, M.S., Boineau, J.P., Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing and Clinical Electrophysiology: PACE 20 (1997), 397–413.
169. Oliveira, W., Poyares, D., Cintra, F., Vieira, M.L.C., Fischer, C.H., Moises, V., et al. Impact of continuous positive airway pressure treatment on right ventricle performance in patients with obstructive sleep apnoea, assessed by three-dimensional echocardiography. Sleep Medicine 13 (2012), 510–516.
170. Oliveira, W., Campos, O., Cintra, F., Matos, L., Vieira, M.L., Rollim, B., et al. Impact of continuous positive airway pressure treatment on left atrial volume and function in patients with obstructive sleep apnoea assessed by real-time three-dimensional echocardiography. Heart (British Cardiac Society) 95 (2009), 1872–1878.
171. Arias, M.A., García-Río, F., Alonso-Fernández, A., Mediano, O., Martínez, I., Villamor, J., Obstructive Sleep Apnea Syndrome Affects Left Ventricular Diastolic Function. Circulation, 112, 2005, 375.
172. Colish, J., Walker, J.R., Elmayergi, N., Almutairi, S., Alharbi, F., Lytwyn, M., et al. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 141 (2012), 674–681.
173. Colish, J., Walker, J.R., Elmayergi, N., Almutairi, S., Alharbi, F., Lytwyn, M., et al. Obstructive Sleep Apnea: Effects of Continuous Positive Airway Pressure on Cardiac Remodeling as Assessed by Cardiac Biomarkers, Echocardiography, and Cardiac MRI. Chest 141 (2012), 674–681.
174. Mitchell, L.J., Davidson, Z.E., Bonham, M., O'Driscoll, D.M., Hamilton, G.S., Truby, H., Weight loss from lifestyle interventions and severity of sleep apnoea: a systematic review and meta-analysis. Sleep Medicine 15 (2014), 1173–1183.
175. McEvoy, R.D., Antic, N.A., Heeley, E., Luo, Y., Ou, Q., Zhang, X., et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. New England Journal of Medicine 375 (2016), 919–931.
176. Zimmerman, M.E., Arnedt, J.T., Stanchina, M., Millman, R.P., Aloia, M.S., Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. Chest 130 (2006), 1772–1778.
177. Weaver, T.E., Maislin, G., Dinges, D.F., Bloxham, T., George, C.F., Greenberg, H., et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30 (2007), 711–719.
178. Sawyer, A.M., Gooneratne, N.S., Marcus, C.L., Ofer, D., Richards, K.C., Weaver, T.E., A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev 15 (2011), 343–356.